|
||||||||||||||||
|
||||||||||||||||
HUM-MOLGEN -> mail archive | Search | register for news alert (free) | |||||||||||||||
Hans Goerl: ETHI: Science and PR | ||||||||||||||||
[Author Prev][Author Next][Thread Prev][Thread Next][Author Index][Topic Index] |
||||||||||||||||
To: HUM-MOLGEN@NIC.SURFNET.NL Subject: ETHI: Science and PR From: Hans Goerl <GENETHICS@delphi.com> Date: Thu, 10 Apr 1997 20:33:21 -0400 Last week, a research team at Stonybrook announced the discovery of high levels of mitogen-activated protein (MAP) kinase levels in biopsied human breast tumor cells. News of the finding was given widespread media coverage, and heralded as a major breakthrough in cancer science. Apparently, the release of the news was orchestrated, in part, by a public relations firm. Scientists often complain about inaccurate and exaggerated media coverage of science news. Yet if scientists work with public relations firms to release scientific "news," are scientists not also responsible for contributing to inaccurate reporting by the media? Doesn't working with public relations firms taint the quality of the science, making it seem like just another product that has to be sold on the market? Do really important discoveries need Madison Avenue to become well known, understood and critically evaluated? Do grant reviewers and budget directors really take press coverage into account when making financial decisions? What would a great scientist like Darwin, who sat on his discovery for decades before releasing it, think of this practice? I am interested in hearing the thoughts of other members of the medical and scientific community. Robert Resta Center for Perinatal Studies Swedish Medical Center Seattle The views expressed are not necessarily those of Swedish Medical Center or the Center for Perinatal Studies.
|
||||||||||||||||
|
||||||||||||||||
Mail converted by |